Site of action for pharmacological agents acting on group I mGlu receptors in the periphery
This table does not include studies performed in sensory cells.
Agent | Site of Action | Effect | References |
---|---|---|---|
Agonists | |||
ACPDa | Adrenal glands | Increased secretion of catecholamines | González et al., 1998 |
Testis | Increased inositol phospholipid hydrolysis | Storto et al., 2001 | |
Enteric neurons | Activation of depolarizing response | ||
Peripheral T cells | Increased survival to apoptosis induced by anti-CD3 | Ren et al., 2000 | |
Hepatocytes | Increased inositol monophosphate formation and hypoxia-induced cell damage | Chiocchetti et al., 2006 | |
Osteoblasts | Reduced NMDA-induced current | Storto et al., 2000b; Sureda et al., 1997 | |
Gu and Publicover, 2000 | |||
CHPGb | Peripheral T cells | Increased survival to apoptosis induced by anti-CD3 | Chiocchetti et al., 2006; Pacheco et al., 2004 |
Enteric neurons | Activation of depolarizing response | Liu and Kirchgessner, 2000 | |
Enteric glia | Increased expression of c-Fos and activation of ERK1/2 | Nasser et al., 2007 | |
DHPG | Chromaffin cells | Increased secretion of catecholamines | Arce et al., 2004 |
Pancreatic β cells | Increased release of insulin at low glucose concentrations | Brice et al., 2002 | |
Duodenum | Increased intracellular pH | Akiba et al., 2009 | |
Enteric neurons | mGlu5 internalization; activation of depolarization; suppression of slow EPSPs | Liu and Kirchgessner, 2000; Ren et al., 1999; 2000 | |
Peripheral T cells | Increased survival to apoptosis induced by anti-CD3 | Chiocchetti et al., 2006; Pacheco et al., 2004 | |
Endothelial cells | Increased paracellular permeability; prevents oxidative damage | Collard et al., 2002; Lin and Maiese, 2001 | |
Cartilage | Decreased mineralization | Wang et al., 2005 | |
Melanocytes | Impaired viability in confluent cultures; proliferation in subconfluent cultures | Frati et al., 2000 | |
Tumor cells | Increased cell migration, invasion, and adhesion | Park et al., 2007 | |
Quisqualate | Hepatocytes | Increased inositol monophosphate formation and hypoxia-induced cell damage | Storto et al., 2000b; Sureda et al., 1997 |
Heart | Increased PLC activity | Iglesias et al., 2007 | |
Melanocytes | Impaired viability in confluent cultures; proliferation in subconfluent cultures | Frati et al., 2000 | |
Stem cells | Increased intracellular Ca2+ levels | Cappuccio et al., 2005 | |
Peripheral T cells | Increased survival to apoptosis induced by anti-CD3 | Chiocchetti et al., 2006 | |
Antagonists | |||
AIDA | Duodenum | Decreases glutamate-induced alkalinization | Akiba et al., 2009 |
Ileum | Suppression of DHPG-induced depolarizing response | Liu and Kirchgessner, 2000 | |
Peripheral T cells | Inhibition of prosurvival effect induced by quisqualate | Chiocchetti et al., 2006 | |
BAY36-7620c | Tumor cells | Reduction in cell proliferation | Namkoong et al., 2007 |
CPCCOEtc | Peripheral T cells | Impaired cytokine production | Pacheco et al., 2006 |
Testis | Inhibition of the ACPD-induced inositol phospholipid hydrolysis | Storto et al., 2001 | |
LY367385c | Tumor cells | Reduction in cell proliferation | Namkoong et al., 2007 |
MPEPb | Peripheral T cells | Increased IL-6 production and inhibition of Glu-induced survival to apoptosis | Chiocchetti et al., 2006; Pacheco et al., 2006 |
Testis | Inhibition of the ACPD-induced inositol phospholipid hydrolysis | Storto et al., 2001 | |
Pancreas | Inhibition of Glu-induced insulin secretion and of glucagon response to insulin | Storto et al., 2006 | |
Hepatocytes/ liver | Protection against hypoxia-, acetaminophen-, and LPS-induced damage | Jesse et al., 2009; Storto et al., 2000b, 2003 | |
Enteric neurons | Reduction of glutamate-induced depolarizing response | Liu and Kirchgessner, 2000 | |
Melanocytes | Prevention of quisqualate-induced effects | Frati et al., 2000 | |
Stem cells | Reduction in markers of undifferentiated state | Cappuccio et al., 2005; Spinsanti et al., 2006 | |
Tumor cells | Inhibition of DHPG-induced cell migration, invasion, and adhesion | Park et al., 2007 | |
PHCCCd | Endothelial cells | Attenuated glutamate-mediated increases in paracellular permeability | Collard et al., 2002 |
Tumor cells | Reduction of proliferation in vitro and tumor mass growth in vivo | Namkoong et al., 2007 | |
S-4-CPG | Enteric neurons | Reduction of DHPG-induced depolarization; suppression of Glu effect on EPSPs | Hu et al., 1999; Liu and Kirchgessner, 2000; Ren et al., 1999; 2000 |
Enteric glia | Abolished intracellular signaling induced by CHPG | Nasser et al., 2007 |
CHPG, (R,S)-2-chloro-5-hydroxyphenylglycine; CPCCOEt, 7-(hydroxyimino)cyclopropa[b]chromen-1α-carboxylate ethyl ester; Quisqualate, (l)-(+)-α-amino-3,5-dioxo-1,2,4-oxadiazolidine-2-propanoic acid; S-4-CPG, (S)-4-carboxyphenylglycine.
↵a Also activates mGlu receptors from group II.
↵b Specific for mGlu5 receptor.
↵c Specific for mGlu1 receptor.
↵d Also activates mGlu4 receptor.